Documents Using genetic markers in clinical practice David Thomas Advisor: Merck Clinical trial: Gilead and...

Slide 1Using genetic markers in clinical practice David Thomas Advisor: Merck Clinical trial: Gilead and Merck Slide 2 Using genetic markers in clinical practice IL28b test…

Technology 2014 FDA Drug Approvals

36 DRUGS 10 COMPANIESDRUGS 2014 YEAR IN REVIEW FDA DRUG APPROVALS Novel Drugs Approved in 2014 AP PR OV ED Type 2 Diabetes Source: FDA.GOV FARXIGA 1 Non­24­Hour Sleep­Wake…

Documents SVR4 and SVR12 with an interferon-free regimen of BI 201335 AND BI 207127, +/- ribavirin, in...

SILEN-C1: Early Antiviral Activity and Safety of BI 201335 Combined with Peginterferon alfa-2a and Ribavirin in Treatment-naïve Patients with Chronic Genotype 1 HCV infection…

Documents Speaker declaration

SILEN-C1: Early Antiviral Activity and Safety of BI 201335 Combined with Peginterferon alfa-2a and Ribavirin in Treatment-naïve Patients with Chronic Genotype 1 HCV infection…